The frequency of KRAS mutations is variable across different cancer types, with mutation rates up to 88% in pancreatic ductal adenocarcinoma (PDAC), 45–50% in colorectal cancer (CRC) and 30–35% in lung adenocarcinoma [1, 2, 7]. This evidence concerns the gene KRAS and cancer.